Lowe Wealth Advisors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Lowe Wealth Advisors’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-100	Closed	-$1K	–	264
2020 Q1	$1K	Hold	100	–	–	﹤0.01%	256
2019 Q4	$2K	Hold	100	–	–	﹤0.01%	235
2019 Q3	$2K	Hold	100	–	–	﹤0.01%	227
2019 Q2	$2K	Hold	100	–	–	﹤0.01%	246
2019 Q1	$2K	Hold	100	–	–	﹤0.01%	213
2018 Q4	$2K	Hold	100	–	–	﹤0.01%	206
2018 Q3	$2K	Hold	100	–	–	﹤0.01%	253
2018 Q2	$2K	Hold	100	–	–	﹤0.01%	197
2018 Q1	$2K	Hold	100	–	–	﹤0.01%	203
2017 Q4	$2K	Hold	100	–	–	﹤0.01%	212
2017 Q3	$2K	Buy	+100	New	+$1.65K	﹤0.01%	204

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lowe Wealth Advisors's AMPH Position: Q2 2020 in Review

Lowe Wealth Advisors sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2020, closing a stake of 100 shares — an estimated $1K sold.

Lowe Wealth Advisors first reported a position in AMPH in Q3 2017 and held it in 11 quarters. The position peaked at $2K in Q4 2019. 135 funds tracked by Wall St. Rank hold AMPH as of Q2 2020.

Lowe Wealth Advisors reported no remaining Amphastar Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Lowe Wealth Advisors sold 100 Amphastar Pharmaceuticals shares in Q2 2020, an estimated $1K.
Lowe Wealth Advisors first reported a position in Amphastar Pharmaceuticals in Q3 2017 and held it in 11 quarters.
Lowe Wealth Advisors's Amphastar Pharmaceuticals position peaked at $2K in Q4 2019.
135 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2020.

Based on Lowe Wealth Advisors's 13F filing for Q2 2020, filed 8 Jul 2020.